Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian, Colorectal or Bronchopulmonary Cancer

ABSTRACT: Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers. The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.

DISEASE(S): Arthralgia

PROVIDER: 2267615 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR